Tergaonkar V - Search Results

1

Small Molecule NF-κB Pathway Inhibitors in Clinic.

Ramadass V, Vaiyapuri T, Tergaonkar V. Ramadass V, et al. Among authors: tergaonkar v. Int J Mol Sci. 2020 Jul 21;21(14):5164. doi: 10.3390/ijms21145164. Int J Mol Sci. 2020. PMID: 32708302 Free PMC article. Review.

2

NFkappaB pathway: a good signaling paradigm and therapeutic target.

Tergaonkar V. Tergaonkar V. Int J Biochem Cell Biol. 2006;38(10):1647-53. doi: 10.1016/j.biocel.2006.03.023. Int J Biochem Cell Biol. 2006. PMID: 16766221 Review.

3

p53 and NF-kappaB crosstalk: IKKalpha tips the balance.

Tergaonkar V, Perkins ND. Tergaonkar V, et al. Mol Cell. 2007 Apr 27;26(2):158-9. doi: 10.1016/j.molcel.2007.04.006. Mol Cell. 2007. PMID: 17466617 Free article. Review.

4

R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.

Dey A, Wong ET, Cheok CF, Tergaonkar V, Lane DP. Dey A, et al. Among authors: tergaonkar v. Cell Death Differ. 2008 Feb;15(2):263-73. doi: 10.1038/sj.cdd.4402257. Epub 2007 Nov 2. Cell Death Differ. 2008. PMID: 17975552

5

Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy.

Dey A, Wong E, Kua N, Teo HL, Tergaonkar V, Lane D. Dey A, et al. Among authors: tergaonkar v. Cell Cycle. 2008 Dec;7(23):3759-67. doi: 10.4161/cc.7.23.7213. Epub 2008 Dec 10. Cell Cycle. 2008. PMID: 19029824

6

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.

Dey A, Tergaonkar V, Lane DP. Dey A, et al. Among authors: tergaonkar v. Nat Rev Drug Discov. 2008 Dec;7(12):1031-40. doi: 10.1038/nrd2759. Nat Rev Drug Discov. 2008. PMID: 19043452 Review.

7

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.

Wong ET, Tergaonkar V. Wong ET, et al. Among authors: tergaonkar v. Clin Sci (Lond). 2009 Mar;116(6):451-65. doi: 10.1042/CS20080502. Clin Sci (Lond). 2009. PMID: 19200055 Review.

8

Potential pharmacological control of the NF-κB pathway.

Sethi G, Tergaonkar V. Sethi G, et al. Among authors: tergaonkar v. Trends Pharmacol Sci. 2009 Jun;30(6):313-21. doi: 10.1016/j.tips.2009.03.004. Epub 2009 May 14. Trends Pharmacol Sci. 2009. PMID: 19446347 Review.

9

Noncanonical NF-κB Signaling in Health and Disease.

Cildir G, Low KC, Tergaonkar V. Cildir G, et al. Among authors: tergaonkar v. Trends Mol Med. 2016 May;22(5):414-429. doi: 10.1016/j.molmed.2016.03.002. Epub 2016 Apr 7. Trends Mol Med. 2016. PMID: 27068135 Review.

10

Noncoding RNAs: Master Regulators of Inflammatory Signaling.

Chew CL, Conos SA, Unal B, Tergaonkar V. Chew CL, et al. Among authors: tergaonkar v. Trends Mol Med. 2018 Jan;24(1):66-84. doi: 10.1016/j.molmed.2017.11.003. Epub 2017 Dec 12. Trends Mol Med. 2018. PMID: 29246760 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page